Access Pharmaceuticals
Access' lead anticancer program is ProLindac™ applies the principals of nanoparticulate prodrugs to enhance the delivery of a platinum drug to tumors.
| Address: | 2600 Stemmons Freeway, Suite 176 |
| City: | Dallas |
| State/Province: | Texas |
| Postcode: | 75207-2107 |
| Country/Region: | USA |
|
